About Acelity
Acelity is a Healthcare company based in San Antonio (United States) founded in 1976, and was acquired by 3M in May 2019. Wound therapeutics and regenerative medicine products are developed globally. Acelity has completed 2 acquisitions, including Crawford Healthcare and Systagenix. Its Indian entity Kci Medical India Private Limited reported revenue of ₹136 Cr. Its focus areas include Diversified Medical Devices.
Company details
Acelity is a privately held globally diversified medical device company. It is a non-operating holding company whose wholly owned subsidiaries develop wound therapeutics and regenerative medicine products. The advanced wound therapeutics business is conducted by Kinetic Concepts and its subsidiaries, including Systagenix, and the regenerative medicine business is conducted by LifeCell. Acelitys products are sold in over 80 countries. Its Advanced wound therapeutics unit produces products including negative pressure wound therapy, negative pressure surgical incision management, and epidermal harvesting. Its Regenerative medicine unit produces products encompassing regenerative and reconstructive acellular tissue matrices for repair of soft tissue defects, as well as autologous fat grafting solutions. Acelity began as Kinetic Concepts Inc., a medical technology company founded in 1976. In October 2013, KCI acquired Systagenix Wound Management, originally Johnson Johnsons professional wound care business for 485 million. In September 2014, KCIs parent company announced that KCI, LifeCell and Sytagenix would operate under one global medical technology brand known as Acelity. Acelity was acquired by Apax partners for 6.3B in 2011.
- Headquarters San Antonio, United States
- Stage Acquired
- SectorsHealthcare
- Website acelity.com
- Social LinkedIn X Facebook
- Acquired by 3M (May 2019)
- Legal Name Kci Medical India Private Limited
- Date of Incorporation 26 Aug, 2010
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹136 Cr
FY 2025 · +148% YoY
- Indian entity net profit₹23.13 Cr
FY 2025 · 17% margin
- Indian entity EBITDA₹20.47 Cr
FY 2025 · 15% margin
- Latest Funding Round$1.64B (USD), Debt – Conventional
Feb 2017
- Investors3M
& 2 more
- Investments & AcquisitionsCrawford Healthcare
& 1 more
- Acquired by
Associated legal entities of Acelity
Acelity operates through Kci Medical India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Kci Medical India Private Limited CIN U51397DL2010FTC207599 | Active | 26 Aug 2010 | New Delhi, Delhi | ₹136 Cr | 3 | View details |
Funding Insights of Acelity
- Total Rounds 2
- Last Round Debt – Conventional — $1.64B
- Investors Count 1
All 2 funding rounds of Acelity with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2017 | $1.64B | Debt – Conventional | – | – | – |
| Jun 2011 | Private Equity Round | – | – |
3 investors in total: 3 institutional.
Investors in Acelity
Acelity has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include 3M, Apax Partners and CPP Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Equity investments are focused on tech, services, and consumer sectors. | 1981 | apax.com | Hong Kong, China | |
Pension fund assets are managed for sustainable long-term growth. | 1997 | cppinvestments.com | Toronto, Canada | |
3M is recognized as a global leader in industrial innovation. | 1902 | 3m.com | United States |
Investor details for Acelity
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Kci Medical India Private Limited (Acelity)
Kci Medical India Private Limited is the primary company behind Acelity. The board of Kci Medical India Private Limited currently have 3 directors; the longest-serving is Kuppanda Ayappa Appiah, appointed in 2019. 16 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kuppanda Ayappa Appiah DIN 07939378 | Director | 14 Oct 2019 | 7 yrs | Kci Medical India Private Limited |
| Inavolu Venkata Jagadish DIN 10198591 | Director | 03 Apr 2024 | 2 yrs 7 mo | Kci Medical India Private Limited |
| Raj Kumar Khemani DIN 09682850 | Whole-time director | 29 Sep 2025 | 1 yr 1 mo | Kci Medical India Private Limited |
People of Acelity
818 people are tracked at Acelity (231 in leadership, 11 in board & advisors, 576 in team).
| Name | Role | Group |
|---|---|---|
Aparna Sardar | Country Head- Human Resources - India | Leadership |
Mark Murphy | EVP & Chief Information & Digital Officer | Leadership |
Delony Langer-Anderson | Technical Director Disruptive Technology And Sustainable Materials | Leadership |
Yolanda O'Brien | HR Services And Transformation Vice President | Leadership |
Melanie Olsen | Director, HR Mergers, Acquisitions & Transitions | Leadership |
Doug Cowan | VP, Global Supply Chain | Leadership |
Srinath R Deshapande | Head - IT Infrastructure And Security - India Region | Leadership |
Gabe Hart | Consulting Director Of Data Platform Engineering (via Wexford Consulting) | Leadership |
Corey Bohnert | Sales Director- US & CAN | Leadership |
Bill Pettit | Global Business Director: Fall Protection | Leadership |
Kimberly Johnson | Director Global Quality | Leadership |
Jon Ruppel | Senior Vice President, Total Rewards And Services | Leadership |
Laura Gagnon | Director, Global Business Process Optimization | Leadership |
Alisha Tack | Vice President Human Resources, Transportation & Electronics Business Group | Leadership |
Anurag Maheshwari | Executive Vice President, Chief Financial Officer | Leadership |
Janel Haider | Business Transformation And IT Director | Leadership |
David Dorgan | Vice President; Supplier Performance & Productivity | Leadership |
Adam Brodd | Global Application Engineering Director | Leadership |
Qujie Sadlo | Finance Director, Global Procurement | Leadership |
Lisa Black | Global Sales Incentive Director | Leadership |
798 more people are available in the full profile.
Complete people profiles for Acelity
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Acelity
Figures of Kci Medical India Private Limited, the primary company behind Acelity, for FY 2025. Revenue was ₹136 Cr (+148% year on year). Net profit was ₹23.13 Cr (17% margin). EBITDA was ₹20.47 Cr (15% margin). Revenue has grown at a compounded annual rate of +53% over three years and +24% over five years.
- ₹136 CrRevenue · FY 2025 · +148% YoY
- ₹23.13 CrNet profit · 17% margin
- ₹20.47 CrEBITDA · 15% margin
- ₹4.00 CrPaid-up capital
- +53%Revenue CAGR, 3 years
- +24%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Kci Medical India Private Limited are on its company page.
Detailed financial statements for Acelity
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Acelity
Acelity has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Crawford Healthcare and Systagenix.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Manufacturer of wound care products | crawfordhealthcare.com | Cheshire, United Kingdom | 1996 | Jun 2018 | •••• | |
Advanced wound therapeutics and regenerative medicine products are developed. | systagenix.com | Horley, United Kingdom | 2008 | Jul 2013 | $485M |
Complete acquisition details for Acelity
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Acelity
7 dated milestones of Acelity across 43 years, from founding to its latest funding, stage changes and deals.
- Founded Acelity is founded.
- Funding First funding round.
- Exit Acquired by Apax.
- Acquisition Acquires Systagenix.
- Funding Latest funding round, Debt – Conventional, of $1.6B.
- Acquisition Acquires Crawford Healthcare.
- Exit Acquired by 3M.
Web traffic of Acelity
Websites that share an audience with Acelity (acelity.com).
Websites whose visitors overlap most with Acelity. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lifecell.com | 100% | View details | |||
| legacymedsearch.com | 92% | #5,132,467 | View details | ||
kcij.com | kcij.com | 91% | – |
Top companies in Diversified Medical Devices
3 companies that operate in the same segment as Acelity (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | USD 36.36 B | 95,000 | ||
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | USD 20.07 B | 53,000 | ||
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | USD 94.18 B | 139,800 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Acelity
Complete news archive for Acelity
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acelity
Acelity was founded in 1976 and raised its 1st funding round 35 years after it was founded.
Acelity is headquartered in San Antonio, United States. It is registered at San Antonio, Texas, United States.
The primary company behind Acelity, Kci Medical India Private Limited, reported revenue of ₹136 Cr for FY 2025, up 148% year on year.
Acelity is a privately held globally diversified medical device company. It is a non-operating holding company whose wholly owned subsidiaries develop wound therapeutics and regenerative medicine products. The advanced wound therapeutics business is conducted by Kinetic Concepts and its subsidiaries, including Systagenix, and the regenerative medicine business is conducted by LifeCell. Acelitys products are sold in over 80 countries. Its Advanced wound therapeutics unit produces products including negative pressure wound therapy, negative pressure surgical incision management, and epidermal harvesting. Its Regenerative medicine unit produces products encompassing regenerative and reconstructive acellular tissue matrices for repair of soft tissue defects, as well as autologous fat grafting solutions. Acelity began as Kinetic Concepts Inc., a medical technology company founded in 1976. In October 2013, KCI acquired Systagenix Wound Management, originally Johnson Johnsons professional wound care business for 485 million. In September 2014, KCIs parent company announced that KCI, LifeCell and Sytagenix would operate under one global medical technology brand known as Acelity. Acelity was acquired by Apax partners for 6.3B in 2011.
Acelity has made 2 acquisitions, including Crawford Healthcare, and Systagenix.
Acelity has 3 investors. Key investors include 3M, Apax Partners, and CPP Investments.
Acelity operates through Kci Medical India Private Limited.
Yes. Acelity was acquired by 3M in May 2019.
The legal entities of Acelity currently have 3 directors, including Raj Kumar Khemani, Inavolu Venkata Jagadish, Kuppanda Ayappa Appiah.

